ERG inhibitors (Oncofusion)

N/A

Report date: 2025/01/26 17:59:05
NME

Base Information

Drug NameERG inhibitors (Oncofusion)
Drug Alias NameRI-EIP
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionTranscriptional regulator ERG degraders
TargetsTranscriptional regulator ERG
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAfghanistan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoFusion Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOncoFusion Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A